feed,title,long_url,short_url
Benzinga,"Cummins Clocks 8% Sales Growth In Q2, Reiterates FY22 Outlook",https://benzinga.com/news/earnings/22/08/28316662/cummins-shares-gain-on-q2-results-beat-reiterates-fy22-outlook,https://bit.ly/3vA0vGx
Benzinga,"Sage Therapeutics, Inc. (SAGE) Reports Q2 Loss, Misses Revenue Estimates",https://benzinga.com/22/08/28310572/sage-therapeutics-inc-sage-reports-q2-loss-misses-revenue-estimates,https://bit.ly/3JpdArX
Benzinga,What's In The Cards For Realty Income (O) In Q2 Earnings?,https://benzinga.com/22/08/28310577/whats-in-the-cards-for-realty-income-o-in-q2-earnings,https://bit.ly/3JnBxjB
